Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study)
- 1 March 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 89 (6) , 662-666
- https://doi.org/10.1016/s0002-9149(01)02336-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery DiseaseNew England Journal of Medicine, 2000
- A prospective study of fibrinogen and risk of myocardial infarction in the physicians’ health studyJournal of the American College of Cardiology, 1999
- Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart DiseaseJAMA, 1998
- Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease: The Caerphilly and Speedwell StudiesEuropean Heart Journal, 1996
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- Apolipoproteins and ischaemic heart disease: implications for screeningThe Lancet, 1994
- The role of fibrinogen as a cardiovascular risk factorAtherosclerosis, 1993
- Fibrinogen and Risk of Cardiovascular DiseaseJAMA, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980